Bluebird bio completes spinout of oncology business 2seventy bio
November 04, 2021 at 16:35 PM EDT
The oncology unit is now its own, publicly traded company, called 2seventy bio, named for what CEO Nick Leschly contends is "the maximum speed of human thought."
